Esene Ignatius Ngene, Mbuagbaw Lawrence, Dechambenoit Gilbert, Reda Wael, Kalangu Kazadi K
Department of Neurological Surgery, University of Wisconsin-Madison, Madison, Wisconsin, USA; Gamma Knife Center, Nasser Institute, Cairo, Egypt.
Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada.
World Neurosurg. 2018 Apr;112:233-242. doi: 10.1016/j.wneu.2018.01.171. Epub 2018 Feb 3.
Case-control studies (CCS) and cohort studies (CS) are common research designs in neurosurgery. But the term case-control study is frequently misused in the neurosurgical literature, with many articles reported as CCS, even although their methodology does not respect the basic components of a CCS. We sought to estimate the extent of these discrepancies in neurosurgical literature, explore factors contributing to mislabeling, and shed some light on study design reporting.
We identified 31 top-ranking pure neurosurgical journals and searched them for articles reported as CCS, either in the title or in the abstract. The articles were read to determine if they really were CCS according to STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) guidelines. Article assessment was conducted in duplicate (agreement [κ statistics] = 99.82%).
Two hundred and twenty-four articles met our inclusion criteria, 133 of which (59.38%) correctly labeled the case-control design, whereas 91 (40.62%) misclassified this study design. Cohort studies (CS) were the most common design mislabeled as case-control studies in 76 articles (33.93%), 57 of which (25.45%) were retrospective CS. The mislabeling of CCS impairs the appropriate indexing, classification, and sorting of evidence. Mislabeling CS for CCS leads to a downgrading of evidence as CS represent the highest level of evidence for observational studies. Odds ratios instead of relative risk are reported for these studies, resulting in a distortion of the measurement of the effect size, compounded when these are summarized in systematic reviews and pooled in meta-analyses.
Many studies reported as CCS are not true CCS. Reporting guidelines should include items that ensure that studies are labeled correctly. STROBE guidelines should be implemented in assessment of observational studies. Researchers in neurosurgery need better training in research methods and terminology. We also recommend accrued vigilance from reviewers and editors.
病例对照研究(CCS)和队列研究(CS)是神经外科常见的研究设计。但在神经外科文献中,“病例对照研究”一词经常被误用,许多文章虽报道为CCS,但其方法并不符合CCS的基本要素。我们试图评估神经外科文献中这些差异的程度,探究导致错误标注的因素,并对研究设计报告予以阐明。
我们确定了31种顶级纯神经外科期刊,并在其中搜索标题或摘要中报道为CCS的文章。根据STROBE(加强流行病学观察性研究报告)指南阅读这些文章,以确定它们是否真的是CCS。文章评估由两人独立进行(一致性[κ统计量]=99.82%)。
224篇文章符合我们的纳入标准,其中133篇(59.38%)正确标注了病例对照设计,而91篇(40.62%)对该研究设计进行了错误分类。队列研究(CS)是最常被错误标注为病例对照研究的设计,在76篇文章(33.93%)中出现,其中57篇(25.45%)为回顾性CS。CCS的错误标注会影响证据的正确索引、分类和排序。将CS错误标注为CCS会导致证据降级,因为CS代表观察性研究的最高证据水平。这些研究报告的是比值比而非相对风险,导致效应大小测量失真,在系统评价中进行总结和荟萃分析合并时情况更复杂。
许多报道为CCS的研究并非真正的CCS。报告指南应包括确保研究正确标注的项目。在观察性研究评估中应实施STROBE指南。神经外科研究人员需要在研究方法和术语方面接受更好的培训。我们还建议审稿人和编辑提高警惕。